Gabriela Borsaru

564 total citations
11 papers, 169 citations indexed

About

Gabriela Borsaru is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Gabriela Borsaru has authored 11 papers receiving a total of 169 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Gabriela Borsaru's work include Lymphoma Diagnosis and Treatment (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Gabriela Borsaru is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Gabriela Borsaru collaborates with scholars based in Romania, Poland and Czechia. Gabriela Borsaru's co-authors include Giuseppe Visani, Giovanni Martinelli, S Tura, Nicoletta Testoni, Emanuela Ottaviani, Rocco Pastano, Paolo F. Ricci, Deborah Ruggeri, Ewa Paszkiewicz‐Kozik and Stefan Henning and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Haematologica.

In The Last Decade

Gabriela Borsaru

10 papers receiving 166 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriela Borsaru Romania 7 111 105 38 28 21 11 169
Galina Tsykunova Norway 8 147 1.3× 103 1.0× 30 0.8× 25 0.9× 10 0.5× 25 200
Maria López‐Pavía Spain 9 108 1.0× 102 1.0× 21 0.6× 31 1.1× 12 0.6× 21 183
Amritha Varshini Hanasoge Somasundara United States 5 59 0.5× 95 0.9× 40 1.1× 50 1.8× 24 1.1× 6 168
Marissa Rashkovan Canada 6 107 1.0× 119 1.1× 31 0.8× 16 0.6× 19 0.9× 7 210
Desmond Wai Loon Chin Singapore 6 106 1.0× 157 1.5× 33 0.9× 41 1.5× 8 0.4× 12 235
Catherine McGuinn United States 8 132 1.2× 58 0.6× 55 1.4× 33 1.2× 51 2.4× 23 191
Andy G.X. Zeng Canada 6 140 1.3× 132 1.3× 35 0.9× 23 0.8× 11 0.5× 16 230
Tiago Maié Germany 7 69 0.6× 99 0.9× 23 0.6× 61 2.2× 10 0.5× 17 181
Mara Molkentin Germany 5 152 1.4× 87 0.8× 38 1.0× 85 3.0× 11 0.5× 6 249
Nur Hezrin Shahrin Australia 5 60 0.5× 52 0.5× 13 0.3× 39 1.4× 15 0.7× 16 130

Countries citing papers authored by Gabriela Borsaru

Since Specialization
Citations

This map shows the geographic impact of Gabriela Borsaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriela Borsaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriela Borsaru more than expected).

Fields of papers citing papers by Gabriela Borsaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriela Borsaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriela Borsaru. The network helps show where Gabriela Borsaru may publish in the future.

Co-authorship network of co-authors of Gabriela Borsaru

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriela Borsaru. A scholar is included among the top collaborators of Gabriela Borsaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriela Borsaru. Gabriela Borsaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Manea, Maria Mirabela, et al.. (2018). Multiple acute ischemic strokes as the onset manifestation of acute promyelocytic leukemia. Romanian Journal of Internal Medicine. 56(4). 265–268. 2 indexed citations
2.
Walewski, Jan, Ewa Paszkiewicz‐Kozik, Gabriela Borsaru, et al.. (2018). Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study. Leukemia & lymphoma. 60(3). 675–684. 20 indexed citations
3.
4.
Coliţă, Andrei, et al.. (2016). Acquired von Willebrand disease: from theory to practice. A single center experience - three case reports. Revista română de medicină de laborator. 24(1). 93–102.
5.
Mateos, María‐Victoria, Tamás Masszi, Norbert Grząśko, et al.. (2016). Impact of prior therapy on efficacy and safety of oral ixazomib-lenalidomide-dexamethasone (IRd) vs placebo-Rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM) in TOURMALINE-MM1.. Journal of Clinical Oncology. 34(15_suppl). 8039–8039. 4 indexed citations
6.
7.
Walewski, Jan, Ewa Paszkiewicz‐Kozik, Gabriela Borsaru, et al.. (2011). Final Results of the Phase II SAPHIRE Trial of Resminostat (4SC-201) in Patients with Relapsed/Refractory Hodgkin Lymphoma. Blood. 118(21). 2675–2675. 7 indexed citations
8.
9.
Walewski, Jan, Ewa Paszkiewicz‐Kozik, Gabriela Borsaru, et al.. (2010). Resminostat In Relapsed or Refractory Hodgkin Lymphoma: Initial Results of the SAPHIRE Phase II Trial with a Novel Oral Histone Deacetylase (HDAC) Inhibitor.. Blood. 116(21). 2811–2811. 6 indexed citations
10.
Martinelli, Giovanni, Emanuela Ottaviani, Silvia Buonamici, et al.. (2003). Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.. PubMed. 88(11). 1221–8. 23 indexed citations
11.
Testoni, Nicoletta, Gabriela Borsaru, Giovanni Martinelli, et al.. (1999). 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features.. PubMed. 84(8). 690–4. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Galina Tsykunova Breakdown of academic impact, for papers by Maria López‐Pavía Breakdown of academic impact, for papers by Amritha Varshini Hanasoge Somasundara Breakdown of academic impact, for papers by Marissa Rashkovan Breakdown of academic impact, for papers by Desmond Wai Loon Chin Breakdown of academic impact, for papers by Catherine McGuinn Breakdown of academic impact, for papers by Andy G.X. Zeng Breakdown of academic impact, for papers by Tiago Maié Breakdown of academic impact, for papers by Mara Molkentin Breakdown of academic impact, for papers by Nur Hezrin Shahrin
Rankless by CCL
2026